Intelligence · Clinical Pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
- Programs
- 1,839
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
-
Tramadol HCI/acetaminophen
Janssen-Cilag Pty Ltd
Cancer
1 trial -
Tranexamic Acid
The First People's Hospital of Lianyungang
Postpartum Hemorrhage, Cesarean Section
1 trial -
Tranexamic Acid 1000 mg/10ml normal saline infusion
United Therapeutics Europe Ltd
Postpartum Hemorrhage
1 trial -
Trangorex 200 mg comprimidos
The George Institute
Atrial fibrillation
1 trial -
Transanal irrigation with Peristeen Anal Irrigation
Stoke Therapeutics
Constipation
1 trial -
Transdermal Nicotine Patch
BRIGHT MINDS BIOSCIENCES INC.
Smoking Cessation
1 trial -
Transdermal nicotine patch
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Transepicardial with Transseptal CD 133+ Implantation
Hospital Authority, Hong Kong
Coronary Artery Disease
1 trial -
Transmucosal Buprenorphine
Indivior Pty Ltd
Moderate to Severe Opioid-use Disorder
1 trial -
Trastuzumab Rezetecan
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Trazodone
United Therapeutics Europe Ltd
Sleep Apnea
1 trial -
Treatment Algorithm A
Takeda
Colitis, Ulcerative
1 trial -
Treatment group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Trelagliptin
Takeda
Type 2 Diabetes Mellitus
2 trials -
Trelagliptin
Takeda
Type 2 Diabetes
1 trial -
Treprostinil
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
3 trials -
Triamcinolone acetonide-Ketorolac-Ropivacaine
United Therapeutics Europe Ltd
Osteoarthritis, Knee
1 trial -
Trimebutine 100 MG
Hospital Authority, Hong Kong
Helicobacter Pylori Infection
1 trial -
Trimetazidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Triple antithrombotic therapy
The First People's Hospital of Lianyungang
Acute Coronary Syndrome (ACS)
1 trial -
Triple combination therapy group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
Triptergium Wilfordii
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Psoriasis Vulgaris
1 trial -
Trivalent live attenuated seasonal influenza vaccine
The University of Hong Kong
Influenza Virus Infection
1 trial -
Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.
Sinovac Research and Development Co.,
COVID-19
1 trial -
Two doses of quadrivalent influenza vaccine
Sinovac Research and Development Co.,
Seasonal Influenza
1 trial -
Typhoid Vi vaccine
International Peace Maternity and Child Health Hospital
Typhoid
1 trial -
USTEKINUMAB, USTEKINUMAB, deucravacitinib
Bristol-Myers Squibb Australia Pty Ltd
Moderate to Severe Plaque Psoriasis
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Multiple Sclerosis
4 trials -
Ultomiris 300 mg/30 mL concentrate for solution for infusion
The George Institute
IgA nephropathy
1 trial -
Ultomiris 300 mg/30 mL concentrate for solution for infusion
Disc Medicine
Paroxysmal nocturnal hemoglobinuria (PNH)
1 trial -
Urapidil Accord 5 mg/ml solución inyectable y para perfusión EFG, Trandate 5mg/ml Solution for Injection, Fenilefrina Altan 0,1 mg/ml solución inyectable y para perfusión.
The George Institute
Acute Ischemic Stroke
1 trial -
Ursodeoxycholic acid combined with total glucosides of paeony
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis
1 trial -
Use of Mitomycin-C (MMC) in trabeculectomy
AEON Biopharma
Glaucoma
1 trial -
Use of an Implantable Loop Recorder
Rhythm Pharmaceuticals Netherlands B.V.
Syncope
1 trial -
VAB-7
The First People's Hospital of Lianyungang
Helicobacter Pylori
1 trial -
VENDY
Summit Therapeutics
Harm Reduction
1 trial -
VENLAFAXINE
Disc Medicine
Major Depressive Disorder
1 trial -
VERAPAMIL , NEBIVOLOL , PROPAFENONE , BISOPROLOL , AMIODARONE , FLECAINIDE , SOTALOL , DILTIAZEM
Pari Pharma GmbH
Asymptomatic Patients with frequent PVCs and normal LVEF
1 trial -
VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg
Pfizer Australia Pty Ltd
Migraine attacks with or without aura
1 trial -
VYEPTI 100 mg concentrate for solution for infusion
H. Lundbeck A/S
Chronic Migrane, Migrane, Medication Overuse Headache
1 trial -
Vabysmo 120 mg/mL solution for injection
Hoffmann-La Roche
Neovascular Age-Related Macular Degeneration
1 trial -
Vabysmo 120 mg/mL solution for injection in pre-filled syringe
The George Institute
SUBRETINAL HYPERREFLECTIVE MATERIAL
1 trial -
Vaccination to prevent hepatitis B virus infection
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis B
1 trial -
Vaicella Vaccine+DTaP on Day 0, MMR on Day 30
Sinovac Research and Development Co.,
Varicella (chickenpox)
1 trial -
Valbenazine
NEUROCRINE BIOSCIENCES INC
Schizophrenia
3 trials -
Valbenazine
NEUROCRINE BIOSCIENCES INC
Tardive Dyskinesia (TD)
2 trials -
Valbenazine Oral Capsule
NEUROCRINE BIOSCIENCES INC
Tardive Dyskinesia
1 trial -
Valproic acid
Hospital Authority, Hong Kong
Drug Resistant Epilepsy
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs